<DOC>
	<DOC>NCT01905735</DOC>
	<brief_summary>the purpose of the study is to assess the safety and efficacy of commonly used Homeopathic medicine Rhustoxicodendron in 30 potency in the treatment of Rheumatoid arthritis.</brief_summary>
	<brief_title>A Safety and Efficacy of Homeopathic Medicine Rhus Toxicodendron 30 in the Treatment of Rheumatoid Arthritis</brief_title>
	<detailed_description>it is a multicenter phase 2 ,double blind study in patient with active Rheumatoid arthritis ,there are 2 group in the study A and B ,where group A receive Rhustoxicodendron in 30 potency the first dose will administered orally (1/2 ml)after the completion of case taking ,and repeated every 7th day for 5 month and on the other hand group B receive placebo orally in (1/2 ml) at same interval for same period .</detailed_description>
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis, Rheumatoid</mesh_term>
	<mesh_term>Ethanol</mesh_term>
	<criteria>those who will provide written consent to participate in the study patient willing to turn up for 7th day follow up patient who are willing and compliance to the study those who are between 25 to 60 years . patient who are willing and compliance to the study . ESR more then 28 mm. Participating as a subject in any other clinical research study. Children below the age of 25years. Female subject who are pregnant or planning for pregnancy within 6 month. History of seizures Breast feeding women's. Patient on treatment for life threatening illness like cancer aids etc. Patient should not have any congenital abnormality or patient should not have undergone any operative procedure as consequences of RA.</criteria>
	<gender>All</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>RA</keyword>
</DOC>